Literature DB >> 28536725

The diagnosis and management of H. pylori infection in Singapore.

Claire Alexandra Zhen Chew1, Tong Fong Lye2, Daphne Ang1, Tiing Leong Ang1.   

Abstract

Helicobacter pylori (H. pylori) is an infection that has a role in causing dyspepsia and complications such as peptic ulcer disease and gastric malignancies. In the primary care setting, one can adopt a stepwise approach with the 'test-and-treat' strategy to manage H. pylori-associated dyspepsia in young patients without alarm symptoms. Empiric first-line therapies should be for a two-week duration; options include clarithromycin-containing triple therapy alone or with the addition of bismuth, concomitant therapy and bismuth quadruple therapy. Post-treatment carbon urea breath test must be performed at least four weeks after the end of treatment to confirm the cure. Options for empiric second-line treatment include bismuth quadruple therapy and levofloxacin-containing triple therapy. Patients with persistent or alarm symptoms should be referred for further evaluation. Patients with persistent infection should be referred for gastroscopy so that gastric biopsies can be obtained for H. pylori culture and antibiotic susceptibility testing. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  H. pylori; acid suppression; antibiotic resistance; dyspepsia

Mesh:

Substances:

Year:  2017        PMID: 28536725      PMCID: PMC5435840          DOI: 10.11622/smedj.2017037

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  45 in total

1.  A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.

Authors:  X Calvet; N García; T López; J P Gisbert; E Gené; M Roque
Journal:  Aliment Pharmacol Ther       Date:  2000-05       Impact factor: 8.171

2.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.

Authors:  Lisette G Capelle; Annemarie C de Vries; Jelle Haringsma; Frank Ter Borg; Richard A de Vries; Marco J Bruno; Herman van Dekken; Jos Meijer; Nicole C T van Grieken; Ernst J Kuipers
Journal:  Gastrointest Endosc       Date:  2010-04-09       Impact factor: 9.427

3.  The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.

Authors:  J Huang; R H Hunt
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

Review 4.  Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis.

Authors:  Javier P Gisbert; Felipe de la Morena; Víctor Abraira
Journal:  Am J Gastroenterol       Date:  2006-06-16       Impact factor: 10.864

5.  Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis.

Authors:  Alexander C Ford; Michelle Qume; Paul Moayyedi; Nicolaas L A Arents; Annmarie T Lassen; Richard F A Logan; Kenneth E L McColl; Paul Myres; Brendan C Delaney
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

6.  Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C urea breath test.

Authors:  Haim Shirin; Arie Levine; Orit Shevah; Vered Shabat-Sehayek; Hussein Aeed; Joram Wardi; Shlomo Birkenfeld; Rami Eliakim; Yona Avni
Journal:  Digestion       Date:  2005-07-12       Impact factor: 3.216

7.  Prospective, multivariate evaluation of CLOtest performance.

Authors:  A P Weston; D R Campbell; R S Hassanein; R Cherian; A Dixon; D H McGregor
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

8.  Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.

Authors:  Jyh-Ming Liou; Chieh-Chang Chen; Chi-Yang Chang; Mei-Jyh Chen; Yu-Jen Fang; Ji-Yuh Lee; Chien-Chuan Chen; Shih-Jer Hsu; Yao-Chun Hsu; Cheng-Hao Tseng; Ping-Huei Tseng; Lawrence Chang; Wen-Hsiung Chang; Hsiu-Po Wang; Chia-Tung Shun; Jeng-Yih Wu; Yi-Chia Lee; Jaw-Town Lin; Ming-Shiang Wu
Journal:  J Antimicrob Chemother       Date:  2012-10-25       Impact factor: 5.790

9.  Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection.

Authors:  Luigi Gatta; Nimish Vakil; Chiara Ricci; John F Osborn; Andrea Tampieri; Federico Perna; Mario Miglioli; Dino Vaira
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

10.  Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.

Authors:  David Y Graham; Yi-Chia Lee; Ming-Shiang Wu
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-08       Impact factor: 11.382

View more
  2 in total

Review 1.  Helicobacter pylori Treatment Strategies in Singapore.

Authors:  Tiing Leong Ang; Daphne Ang
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

Review 2.  Vitamin C: A Preventative, Therapeutic Agent Against Helicobacter pylori.

Authors:  Azhar Hussain; Elsa Tabrez; Jagannadha Peela; Prasanna Honnavar; Shams S M Tabrez
Journal:  Cureus       Date:  2018-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.